Aortopathy: Effects of Lipid-Lowering Therapy

Area of Science:

• Cardiovascular Medicine
• Vascular Biology
• Lipid Metabolism

Background:

• Aortopathies, including abdominal aortic aneurysm and degenerative aortic stenosis, are linked to dyslipidemia.
• Effective prevention strategies for these conditions remain a challenge.

Purpose of the Study:

• To review the role of lipid-lowering therapies in managing and preventing aortopathies.
• To assess the efficacy of statins and explore potential benefits of PCSK9 inhibitors.

Main Methods:

• Literature review of studies investigating dyslipidemia and aortopathies.
• Analysis of existing data on statin efficacy in different aortopathy manifestations.
• Exploration of emerging therapies like PCSK9 inhibitors.

Main Results:

• Statins demonstrated a protective effect in patients with aortic atheroma.
• No current benefit of statins in treating or preventing the progression of calcific aortic stenosis.
• Statins present a favorable risk-to-benefit profile for abdominal aortic aneurysms, warranting further investigation.

Conclusions:

• Lipid-lowering therapy is crucial for aortopathy management.
• Statins are beneficial for aortic atheroma and abdominal aortic aneurysms but not calcific aortic stenosis.
• Further research into PCSK9 inhibitors may offer broader therapeutic potential for aortopathies.